IE
IE · IE · IE-PA-EU/1/19/1404/010-011
RINVOQ 45 mg prolonged-release tablets
ATC L04AA44
Last synced from HPRA (Ireland) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryIE (IE)
ATC codeL04AA44
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/19/1404/010-011
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Prolonged-release tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AA",
"L04AA44"
],
"strength": null,
"pa_number": "EU/1/19/1404/010-011",
"substances": [
"Upadacitinib Hemihydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "27/07/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code L04AA44.
Access this data programmatically
Query RINVOQ 45 mg prolonged-release tablets and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.